1. Home
  2. OMEX vs HBIO Comparison

OMEX vs HBIO Comparison

Compare OMEX & HBIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Odyssey Marine Exploration Inc.

OMEX

Odyssey Marine Exploration Inc.

SELL

Current Price

$9.65

Market Cap

25.4M

ML Signal

SELL

Logo Harvard Bioscience Inc.

HBIO

Harvard Bioscience Inc.

SELL

Current Price

$9.41

Market Cap

26.5M

Sector

Industrials

ML Signal

SELL

Company Overview

Basic Information
Metric
OMEX
HBIO
Founded
1986
1901
Country
United States
United States
Employees
N/A
N/A
Industry
Marine Transportation
Biotechnology: Laboratory Analytical Instruments
Sector
Consumer Discretionary
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
25.4M
26.5M
IPO Year
2024
2000

Fundamental Metrics

Financial Performance
Metric
OMEX
HBIO
Price
$9.65
$9.41
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
★ 153.8K
27.1K
Earning Date
11-02-2026
11-10-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ N/A
EPS
N/A
★ N/A
Revenue
$9,327.00
★ $116,176,000.00
Revenue This Year
N/A
$4.09
Revenue Next Year
N/A
$5.22
P/E Ratio
N/A
★ N/A
Revenue Growth
N/A
★ N/A
52 Week Low
$0.48
$0.40
52 Week High
$14.00
$10.20

Technical Indicators

Market Signals
Indicator
OMEX
HBIO
Relative Strength Index (RSI) 62.96 55.39
Support Level $0.87 $8.01
Resistance Level $14.00 N/A
Average True Range (ATR) 0.99 0.53
MACD -0.11 0.05
Stochastic Oscillator 63.93 42.58

Price Performance

Historical Comparison
OMEX
HBIO

About OMEX Odyssey Marine Exploration Inc.

Odyssey Marine Exploration Inc is a deep-ocean exploration company. It discovers, validates, and develops high-value seafloor mineral resources and provides specialized mineral exploration, project development, and marine services to its clients. The company's subsea project portfolio contains multiple projects in various stages of development, such as the Phosagmex Project, a rich deposit of phosphate sands located seventy-ninety meters deep within the Mexican EEZ; two polymetallic nodule exploration license holders in the Cook Islands' EEZ; the Lihir Gold Project, a subsea area that contains several prospective gold exploration targets located in the Papua New Guinea Exclusive Economic Zone (EEZ); and others.

About HBIO Harvard Bioscience Inc.

Harvard Bioscience Inc is a developer, manufacturer, and seller of technologies, products, and services that enable advances in life science applications, including research, drug and therapy discovery, bioproduction, and preclinical testing. The company organizes its product line into two product families: Cellular and Molecular Technologies (CMT) and Preclinical. The CMT product family supports molecular, cellular, organ, and organoid research, as well as bioproduction and in vitro testing, while the Preclinical product family provides products for preclinical research and testing, including data collection and analysis for safety and regulatory compliance. Its geographical segments include the Americas, Europe, Middle East and Africa, and Asia.

Share on Social Networks: